Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,236.00    -2.00 (-0.16%)
Bid:
1,239.00
Ask:
1,240.00
Spread: 1.00 (0.081%)
Market Cap: £854.29m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisition

14 Nov 2008 07:00

RNS Number : 1504I
CVS Group plc
14 November 2008
Β 

ο»Ώ

For immediate release
14 November 2008

CVS Group plc

("CVS" or the "Company")

Acquisition of TheΒ VillageΒ AnimalΒ HospitalΒ 

CVS, one of theΒ UK's leading providers of veterinary services, is pleased to announce the acquisition ofΒ aΒ fourΒ surgery Surrey based practice,Β The Village Animal HospitalΒ ("VAH").Β Β VAHΒ centres itsΒ operation on the main facility in Caterham, with branches in Redhill, Oxted and Smallfield.

The Caterham surgeryΒ isΒ a state of theΒ artΒ animalΒ hospital, includingΒ extensive in-house laboratory facilities, operating theatres and diagnostic facilities,Β fromΒ whichΒ VAHΒ provides a multidiscipline service for small animal patients withΒ access toΒ expertΒ clinicians inΒ mostΒ major fields of veterinary medicine.Β 

CVS will assume all management responsibilities forΒ VAHΒ following completion of the acquisition including the current employees, which compriseΒ 8 professional vetsΒ amongstΒ a total staff of 44. In line with CVS' strategy, all administration will be consolidated within CVS' centralΒ facilities, providing scope forΒ cost synergies and benefits following the acquisition.

In the year endedΒ 31st July 2007,Β VAHΒ achieved anΒ EBITDAΒ of Β£145,000Β on turnover of Β£1.67m.Β The unaudited turnover for the year ended 31st July 2008Β amounted to Β£1.85m.Β The value of the fixed assets ofΒ VAHΒ to be acquired is Β£147,000.

The acquisition is a further enhancement, both geographically and operationally, to CVS' existing portfolio of 151 veterinary surgeries, 6 veterinary laboratoriesΒ andΒ 1 pet crematorium.Β In line with CVS' stated strategy,Β the acquisition ofΒ VAHΒ offers opportunities, through integration,Β forΒ cost efficiencies andΒ improvedΒ shareholderΒ  returns.

Commenting on the acquisition, CVS Chief Executive Simon Innes said:Β 

"The acquisition ofΒ VillageΒ AnimalΒ HospitalΒ is an excellent one for CVS. The state of the art facilities provide us with a major offering within the South EastΒ andΒ sits alongside the 17 surgeriesΒ thatΒ CVSΒ alreadyΒ owns in theΒ region.

The acquisition of this animal hospital is in keeping with our aim toΒ provide clinical excellence with an exceptional level of client service.Β VAHΒ provides a significantΒ opportunityΒ to enhanceΒ shareholder returns,Β as withΒ all acquisitions integratedΒ into the CVS Group to date."

Contacts:

CVS Group plc
01379 644 288
Simon Innes, Chief Executive
Paul Coxon, Finance Director
Β 
Β 
Β 
Buchanan Communications
020 7466 5000
Richard Oldworth
Ben Romney
Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQILFFDLVLVLIT
Date   Source Headline
30th Nov 20227:00 amRNSExercise of Options and Total Voting Rights
25th Nov 20224:22 pmRNSSAYE Option Scheme & PDMR Dealing
23rd Nov 20222:31 pmRNSResult of AGM
23rd Nov 20227:00 amRNSAGM Statement and Trading Update
8th Nov 20227:00 amRNSCapital Markets Day
31st Oct 20227:00 amRNSExercise of Options and Total Voting Rights
28th Oct 202210:22 amRNSAnnual Report, Notice of AGM & Dividend Timetable
12th Oct 202210:52 amRNSHolding(s) in Company
7th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20224:19 pmRNSLong Term Incentive Plan Awards and PDMR Dealing
30th Sep 20227:00 amRNSExercise of Options and Total Voting Rights
29th Sep 202210:34 amRNSHolding(s) in Company
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20224:19 pmRNSDirector/PDMR Shareholding
26th Sep 202211:56 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSFinal Results for the year ended 30 June 2022
31st Aug 20227:00 amRNSExercise of Options and Total Voting Rights
9th Aug 20229:30 amRNSHolding(s) in Company
29th Jul 20227:00 amRNSExercise of Options and Total Voting Rights
28th Jul 20227:00 amRNSTrading Update
13th Jul 20227:00 amRNSAppointment of Nominated Advisor and Joint Brokers
12th Jul 20227:00 amRNSBlock Listing Interim Review and TVR Update
1st Jul 20227:00 amRNSConclusion of CMA process, acquisition and trading
30th Jun 20227:00 amRNSExercise of Options and Total Voting Rights
13th Jun 20223:00 pmRNSPostponement to Capital Markets Day
8th Jun 20221:54 pmRNSHolding(s) in Company
31st May 20227:00 amRNSExercise of Options and Total Voting Rights
6th May 20227:00 amRNSAcquisition of Anton Vets
29th Apr 20227:00 amRNSExercise of Options and Total Voting Rights
31st Mar 20227:00 amRNSExercise of Options and Total Voting Rights
28th Mar 202210:47 amRNSHolding(s) in Company
24th Mar 20222:54 pmRNSDirector/PDMR Shareholding
24th Mar 202210:03 amRNSHolding(s) in Company
24th Mar 20227:00 amRNSInterim Results
21st Mar 20229:14 amRNSHolding(s) in Company
18th Mar 202210:17 amRNSHolding(s) in Company
3rd Mar 20228:38 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSExercise of Options and Total Voting Rights
21st Feb 20225:37 pmRNSHolding(s) in Company
18th Feb 20227:15 amRNSCMA Update
3rd Feb 20229:43 amRNSHolding(s) in Company
31st Jan 20227:00 amRNSExercise of Options and Total Voting Rights
27th Jan 20227:00 amRNSTrading Update
13th Jan 20221:43 pmRNSBlock Listing Interim Review and TVR Update
4th Jan 20227:00 amRNSExercise of Options, PDMR Dealing and TVR
31st Dec 20217:00 amRNSExercise of Options and Total Voting Rights
22nd Dec 20212:37 pmRNSBlock Listing Application
17th Dec 20211:41 pmRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.